Investor Watch

Category

Washington University School of Medicine in St. Louis Licenses Inhalable COVID-19 Vaccine to India’s Bharat Biotech

In August, TrialSite reported on the promising, preclinical stage vaccine for COVID-19 under development at Washington University School of Medicine (WUSM), St. Louis. That investigational product received attention from around the globe, TrialSite can attest...

Lilly’s Monoclonal Antibody Produces Positive Data, Company Gears up for Further Review & Inks Production Deal with Amgen

TrialSite News reported on Aug 22 that a South Texas trial site location reported growing confidence in a SARS-CoV-2 neutralizing antibody-based investigational product developed by Eli Lilly (Lilly) called LY-CoV555. Developed with the help of powerful discovery...

Pin It on Pinterest